Amplification of HER2 is not involved in resistance to docetaxel in breast cancer cell lines.

Sarah McDonald, David A J Stevenson, Steven Darryll Heys, Andrew Craig Schofield

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)820-821
Number of pages1
JournalEuropean Journal of Surgical Oncology
Volume29
Publication statusPublished - 2003

Cite this

McDonald, S., Stevenson, D. A. J., Heys, S. D., & Schofield, A. C. (2003). Amplification of HER2 is not involved in resistance to docetaxel in breast cancer cell lines. European Journal of Surgical Oncology, 29, 820-821.

Amplification of HER2 is not involved in resistance to docetaxel in breast cancer cell lines. / McDonald, Sarah; Stevenson, David A J; Heys, Steven Darryll; Schofield, Andrew Craig.

In: European Journal of Surgical Oncology, Vol. 29, 2003, p. 820-821.

Research output: Contribution to journalArticle

McDonald, Sarah ; Stevenson, David A J ; Heys, Steven Darryll ; Schofield, Andrew Craig. / Amplification of HER2 is not involved in resistance to docetaxel in breast cancer cell lines. In: European Journal of Surgical Oncology. 2003 ; Vol. 29. pp. 820-821.
@article{1ff4157764714850959970f270563f4c,
title = "Amplification of HER2 is not involved in resistance to docetaxel in breast cancer cell lines.",
author = "Sarah McDonald and Stevenson, {David A J} and Heys, {Steven Darryll} and Schofield, {Andrew Craig}",
year = "2003",
language = "English",
volume = "29",
pages = "820--821",
journal = "European Journal of Surgical Oncology",
issn = "0748-7983",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Amplification of HER2 is not involved in resistance to docetaxel in breast cancer cell lines.

AU - McDonald, Sarah

AU - Stevenson, David A J

AU - Heys, Steven Darryll

AU - Schofield, Andrew Craig

PY - 2003

Y1 - 2003

M3 - Article

VL - 29

SP - 820

EP - 821

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

SN - 0748-7983

ER -